DeepALM: A Context-Aware Deep Learning Framework for Antimicrobial Peptide Prediction
Meiling Wang, Zhaoqi Song, Qing Liu, Furong Tang, Ziwei Wang, Fenglong YangIntroduction:
Antimicrobial peptides (AMPs) are pivotal for developing novel antibiotics to combat escalating drug resistance, yet current computational prediction methods lack sufficient precision for reliable drug discovery.
Methods:
The study introduces a DeepALM (Deep Antimicrobial peptide Learning Model), a context- aware deep learning framework that leverages Natural Language Processing (NLP) to enhance AMP classification. It integrates Text Convolutional Neural Networks (TextCNN), Bidirectional Long Short-Term Memory Networks (BiLSTM), and Attention Mechanisms into a novel TextCNNBiLSTM- Attention architecture that captures contextual sequence features.
results:
1.DeepALM Performance DeepALM’s TextCNN-BiLSTM-Attention model achieved an accuracy of 89.56% on the test set, outperforming TextCNN-BiRNN, Transformer, and BERT (Fig. 5a,b). The model excelled in accuracy, precision, and F1-score, though the cAMP baseline showed a lower FPR, and Transformer had higher recall. 2.Model Interpretability Feature visualization via t-SNE (Fig. 5c) revealed that the TextCNN layer clusters AMP and non-AMP samples with some overlap, while BiLSTM and Attention layers achieve clear separation. This indicates effective feature extraction, capturing biologically relevant sequence patterns such as hydrophobicity and charge distribution, critical for AMP activity.
Results:
Evaluated on benchmark datasets, DeepALM achieves an accuracy of 91.63%, outperforming established models like Transformer and BERT. It also provides interpretable insights into the biological and physicochemical properties that drive predictions.
Discussion:
DeepALM’s performance benefits from BiLSTM’s bidirectional sequence dependency capture and Attention’s focus on key regions. While it aligns with features like hydrophilicity and charge, exploring properties such as the isoelectric point remains a future direction. Integrating structural analysis and multimodal frameworks is proposed to advance the field further.
Conclusion:
DeepALM represents a significant advancement in AMP classification, with high accuracy and interpretability. It serves as a robust tool for AMP-based drug development, and future work will integrate physicochemical and structural analyses to enhance utility.